Table 2.
Relevant cost factors as well as sources and descriptions.
| Cost factor | Costsa | Reasons and description |
| Device costs | €437.65 | The price was derived from the most popular PPGb AFc screening device, the Apple Watch Series 5 [12]. An integrated algorithm diagnoses AF automatically. Trained personnel for interpretation is not needed. |
| Visit to the doctor and diagnostics | €67.23 | Physician visit: ordination and consultation, €13.20; urgent care, €12.90; and telemedical care, €9.52. Diagnostics: long-term ECG and 12-lead ECG, €9.96; stress ECG, €21.65; derived from the study of McBride et al [13] and adapted to current conditions [14]. |
| Medication costs for oral anticoagulation (NOACd) | €1226 | The use of rivaroxaban was assumed because it is the most prescribed NOAC in Germany [15].e |
| Per year costs incurred after surviving a stroke | €15,753 (year 1), €4480 (year 2)… €1481 (year 10) | Interpolation and extrapolation of costs derived from the study of Kolominsky-Rabas et al [16] (Figure 3).e |
| Costs for major bleeding | €1995 | Directly derived from the study of Reinhold et al [6]. |
| Annual discounting rate | 3% | Own assumption. |
a€1=US $1.12.
bPPG: photoplethysmography.
cAF: atrial fibrillation.
dNOAC: non–vitamin K antagonist.
eThe program was realized using unrounded amounts in Euro.